It thus may be inferred that the reduced expression of MED10 (and by inference, pluripotency factors) “cause preferential loss of expression of super-enhancer-associated genes” which are essential for maintaining “cancer cell identity” and promoting oncogene transcription (40, 41). Here, MED10 is linked to cancer.